2026 ICD-10-CM Diagnosis Code C7A.093Malignant carcinoid tumor of the kidney

ICD-10-CM Codes›C00–D49›C7A›C7A

ICD-10-CM C7A.093
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C7A.093 is a billable ICD-10-CM diagnosis code for malignant carcinoid tumor of the kidney. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 656 through 658, 686 through 688. Coders also document this condition as well-differentiated neuroendocrine tumor of kidney. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Malignant neuroendocrine tumors.

Code Identity

ICD-10-CM Code
C7A.093
Billable Status
Yes — Valid for Submission
Code Describes
Malignant carcinoid tumor of the kidney
Short Description
Malignant carcinoid tumor of the kidney
Same as the full description in the CMS dataset.
Parent Code
C7A.09
Malignant carcinoid tumors of other sites

Code Classification

ChapterC00–D49Neoplasms
SectionC7AMalignant neuroendocrine tumors
CategoryC7AMalignant neuroendocrine tumors
This CodeC7A.093Malignant carcinoid tumor of the kidney

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Well-differentiated neuroendocrine tumor of kidney
  • Well-differentiated neuroendocrine tumor of left kidney
  • Well-differentiated neuroendocrine tumor of right kidney

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Tumor
      • carcinoid
        • malignant
          • kidney

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO066
Malignant neuroendocrine tumors
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Carcinoid Tumors

Carcinoid tumors are rare, slow-growing cancers. They usually start in the lining of the digestive tract or in the lungs. They grow slowly and don't produce symptoms in the early stages. As a result, the average age of people diagnosed with digestive or lung carcinoids is about 60.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert C7A.093 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
209.24 Malig carcinoid kidney
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C7A.093Overview

Is C7A.093 (Malignant carcinoid tumors of other sites) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report malignant carcinoid tumor of the kidney on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does C7A.093 group to?

When malignant carcinoid tumor of the kidney is the principal diagnosis on an inpatient stay, it groups to MS-DRG 656, 657, 658, 686, 687, 688, with relative weights from 0.7903 to 3.1838 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of C7A.093?

Under the General Equivalence Mappings, malignant carcinoid tumor of the kidney converts to ICD-9-CM 209.24 (malig carcinoid kidney). The mapping is a direct match.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.